In this episode we welcome back Arthur de Cordova, CEO of Ziel, to discuss the company's presence in the German cannabis market. We explore the differences between the medical market in Europe and the recreational market in the United States, emphasizing the importance of quality and regulatory compliance. We also touch on the potential role of the FDA in safeguarding quality in the US cannabis industry. Arthur highlights Ziel's innovative microbial control solution and their sleek RFX machine.